These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 25687060)
1. [Effects of nuclear factor of kappa B decoy oligodeoxynucleotides on murine with multiple myeloma]. Shi KH; Jiang HL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):132-6. PubMed ID: 25687060 [TBL] [Abstract][Full Text] [Related]
2. [Transfection of nuclear factor-kappaB decoy oligodeoxynucleotides prevents ischemic acute renal failure in rats]. Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1597-602. PubMed ID: 14642117 [TBL] [Abstract][Full Text] [Related]
3. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403 [TBL] [Abstract][Full Text] [Related]
4. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330 [TBL] [Abstract][Full Text] [Related]
6. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Tomita T; Takeuchi E; Tomita N; Morishita R; Kaneko M; Yamamoto K; Nakase T; Seki H; Kato K; Kaneda Y; Ochi T Arthritis Rheum; 1999 Dec; 42(12):2532-42. PubMed ID: 10615998 [TBL] [Abstract][Full Text] [Related]
7. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model. Uemura T; Tsujii M; Akeda K; Iino T; Satonaka H; Hasegawa M; Sudo A J Gene Med; 2012 Nov; 14(11):623-31. PubMed ID: 23080520 [TBL] [Abstract][Full Text] [Related]
8. [Effect of nuclear factor-kappa B decoy oligodeoxynucleotides on IL-10, IL-13 and nuclear factor-kappa B protein expressions in rabbits with severe lung contusion]. Fang DQ; Yu T; Wan L Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2284-7. PubMed ID: 20965826 [TBL] [Abstract][Full Text] [Related]
9. [The inhibitory effects of dumb-bell decoy oligodeoxynucleotides targeting NF-kappaB on the growth of multiple myeloma cells and IL-6 expression]. Jiang HL; Xue WJ; Liu H; Chen W Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):47-50. PubMed ID: 16388744 [TBL] [Abstract][Full Text] [Related]
10. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model. Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880 [TBL] [Abstract][Full Text] [Related]
11. [Influence of nuclear factor-kappaB decoy transfection on nuclear factor-kappaB activity and vascular endothelial growth factor/urokinase-type plasminogen activator/intercellular cell adhesion molecule-1 level of SKOV3 cells]. Lu JP; Sun H; Cao CC; Ou ZL Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):533-7. PubMed ID: 15363352 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor kappaB and ets transcription factors. Nakashima H; Aoki M; Miyake T; Kawasaki T; Iwai M; Jo N; Oishi M; Kataoka K; Ohgi S; Ogihara T; Kaneda Y; Morishita R Circulation; 2004 Jan; 109(1):132-8. PubMed ID: 14662712 [TBL] [Abstract][Full Text] [Related]
14. Transfection of naked nuclear factor-κB decoy oligodeoxynucleotides into liver by rapid portal vein infusion in rats: its effect on ischemia-reperfusion injury of liver. Watanabe G; Uchinami H; Yoshioka M; Abe Y; Kikuchi I; Iwasaki W; Kume M; Yamamoto Y Hum Gene Ther; 2012 Apr; 23(4):428-36. PubMed ID: 22397701 [TBL] [Abstract][Full Text] [Related]
15. Potential protective effect of nuclear factor-κB decoy oligodeoxynucleotides on endotoxin-induced liver injury. Li JD; Peng Y; Li Q; Xiao JW; Gong JP; Liu ZJ Transplant Proc; 2011 Dec; 43(10):3613-7. PubMed ID: 22172814 [TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis. Matsuda N; Hattori Y; Jesmin S; Gando S Mol Pharmacol; 2005 Apr; 67(4):1018-25. PubMed ID: 15576632 [TBL] [Abstract][Full Text] [Related]
17. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis. Son G; Iimuro Y; Seki E; Hirano T; Kaneda Y; Fujimoto J Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G631-9. PubMed ID: 17640975 [TBL] [Abstract][Full Text] [Related]
19. [Influence of nuclear factor-kappaB decoy oligonucleotides on RANTES expression and monocyte chemotactic activity in stromal cells of ectopic endometrium]. Wang XL; Han SP; Fang CL; Mao YD; Wang W; Lu J; Zhang HM Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):518-22. PubMed ID: 19080516 [TBL] [Abstract][Full Text] [Related]
20. Effect of NF-κB decoy oligodeoxynucleotide on LPS/high-fat diet-induced atherosclerosis in an animal model. Kim SJ; Park JH; Kim KH; Lee WR; Lee S; Kwon OC; Kim KS; Park KK Basic Clin Pharmacol Toxicol; 2010 Dec; 107(6):925-30. PubMed ID: 20649557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]